BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 14668731)

  • 1. Peak stimulated insulin secretion is associated with specific changes in gene expression profiles in sporadic insulinomas.
    Kayton ML; Costouros NG; Lorang D; Alexander HR; Hewitt SM; Cochran C; Shalev A; Harlan D; Skarulis MC; Gorden P; Libutti SK
    Surgery; 2003 Dec; 134(6):982-7; discussion 987-8. PubMed ID: 14668731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional consequences of oestrogen and progesterone receptors in human insulinomas.
    Alabraba EB; Taniere P; Reynolds GM; Stewart PM; Wigmore SJ; Bramhall SR
    Endocr Relat Cancer; 2007 Dec; 14(4):1081-8. PubMed ID: 18045959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No constant relationship between islet amyloid polypeptide (IAPP) and insulin expression in insulinomas.
    Nieuwenhuis MG; van Mansfeld AD; van Unnik JA; Berends MJ; Lips CJ
    Neth J Med; 1992 Dec; 41(5-6):264-71. PubMed ID: 1362976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression profiling in insulinomas of Men1 beta-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic beta-cell tumorigenesis.
    Fontanière S; Tost J; Wierinckx A; Lachuer J; Lu J; Hussein N; Busato F; Gut I; Wang ZQ; Zhang CX
    Endocr Relat Cancer; 2006 Dec; 13(4):1223-36. PubMed ID: 17158767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced TGF-beta1 expression and its target genes in human insulinomas.
    Nabokikh A; Ilhan A; Bilban M; Gartner W; Vila G; Niederle B; Nielsen JH; Wagner O; Base W; Luger A; Wagner L
    Exp Clin Endocrinol Diabetes; 2007 Nov; 115(10):674-82. PubMed ID: 18058603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL12/SDF-1 over-expression in human insulinomas and its biological relevance.
    Ilhan A; Nabokikh A; Maj M; Vidakovic M; Nielsen JH; Prikoszovich T; Niederle B; Base W; Luger A; Wagner L
    Mol Cell Endocrinol; 2009 Jan; 298(1-2):1-10. PubMed ID: 19013212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of selected genes in neuroendocrine tumours: insulinomas and phaeochromocytomas.
    Hrasćan R; Pećina-Slaus N; Martić TN; Colić JF; Gall-Troselj K; Pavelić K; Karapandza N
    J Neuroendocrinol; 2008 Aug; 20(8):1015-22. PubMed ID: 18510707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia.
    Anlauf M; Bauersfeld J; Raffel A; Koch CA; Henopp T; Alkatout I; Schmitt A; Weber A; Kruse ML; Braunstein S; Kaserer K; Brauckhoff M; Dralle H; Moch H; Heitz PU; Komminoth P; Knoefel WT; Perren A; Klöppel G
    Am J Surg Pathol; 2009 Mar; 33(3):339-46. PubMed ID: 19011561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gland size is associated with changes in gene expression profiles in sporadic parathyroid adenomas.
    Rosen JE; Costouros NG; Lorang D; Burns AL; Alexander HR; Skarulis MC; Cochran C; Pingpank JF; Marx SJ; Spiegel AM; Libutti SK
    Ann Surg Oncol; 2005 May; 12(5):412-6. PubMed ID: 15915376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinomas and expression of an insulin splice variant.
    Minn AH; Kayton M; Lorang D; Hoffmann SC; Harlan DM; Libutti SK; Shalev A
    Lancet; 2004 Jan; 363(9406):363-7. PubMed ID: 15070567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization and surgical treatment of the pancreatic insulinomas.
    Chung JC; Choi SH; Jo SH; Heo JS; Choi DW; Kim YI
    ANZ J Surg; 2006 Dec; 76(12):1051-5. PubMed ID: 17199688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas.
    de Sá SV; Corrêa-Giannella ML; Machado MC; de Souza JJ; Pereira MA; Patzina RA; Siqueira SA; Machado MC; Giannella-Neto D
    Endocr Relat Cancer; 2006 Mar; 13(1):69-78. PubMed ID: 16601280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
    Soto A; DelRaso NJ; Schlager JJ; Chan VT
    Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
    Iacobuzio-Donahue CA; Ashfaq R; Maitra A; Adsay NV; Shen-Ong GL; Berg K; Hollingsworth MA; Cameron JL; Yeo CJ; Kern SE; Goggins M; Hruban RH
    Cancer Res; 2003 Dec; 63(24):8614-22. PubMed ID: 14695172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiles of progressive pancreatic endocrine tumours and their liver metastases reveal potential novel markers and therapeutic targets.
    Capurso G; Lattimore S; Crnogorac-Jurcevic T; Panzuto F; Milione M; Bhakta V; Campanini N; Swift SM; Bordi C; Delle Fave G; Lemoine NR
    Endocr Relat Cancer; 2006 Jun; 13(2):541-58. PubMed ID: 16728581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The surgical management of insulinoma.
    Vázquez Quintana E
    Bol Asoc Med P R; 2004; 96(1):33-8. PubMed ID: 15575328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of down-regulation of E-cadherin detected in benign sporadic insulinomas by multiplex ligation-dependent probe amplification.
    Jia H; Jiang X; Zhao Z; Ge Y; Lu J; Zhao Y; Cui B; Ning G
    Hum Pathol; 2009 Sep; 40(9):1336-41. PubMed ID: 19427668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis.
    Reece EA; Ji I; Wu YK; Zhao Z
    Am J Obstet Gynecol; 2006 Oct; 195(4):1075-80. PubMed ID: 17000240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA copy number status is a powerful predictor of poor survival in endocrine pancreatic tumor patients.
    Jonkers YM; Claessen SM; Perren A; Schmitt AM; Hofland LJ; de Herder W; de Krijger RR; Verhofstad AA; Hermus AR; Kummer JA; Skogseid B; Volante M; Voogd AC; Ramaekers FC; Speel EJ
    Endocr Relat Cancer; 2007 Sep; 14(3):769-79. PubMed ID: 17914106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical approach and perioperative complications determine short-term outcomes in patients with insulinoma: results of a bi-institutional study.
    Roland CL; Lo CY; Miller BS; Holt S; Nwariaku FE
    Ann Surg Oncol; 2008 Dec; 15(12):3532-7. PubMed ID: 18825460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.